Abbott and Bioscience Launch Strategic Partnership for Rapid Respiratory Infection Testing
On September 18, Bioscience announced the signing of a strategic cooperation agreement with Abbott, a global healthcare leader. The partnership will focus on three colloidal gold rapid testing products for respiratory infections, covering adenovirus antigen, respiratory syncytial virus (RSV) antigen, and Mycoplasma pneumoniae antigen. By combining product capabilities with channel strengths, the two companies aim to accelerate innovation and market development in rapid respiratory infection testing and build a new ecosystem for accessible and efficient diagnostics.
Siemens Healthineers Diagnostics and DIRUI Medical Sign Strategic Cooperation
On September 12, during the China International Medical and Healthcare Industry Development & Investment Forum held at CIFTIS, Siemens Healthineers Diagnostics and DIRUI Medical Technology Co., Ltd. officially signed a strategic cooperation agreement. Leveraging Siemens’ comprehensive laboratory diagnostics portfolio and advanced technologies alongside DIRUI Medical’s local innovation capabilities, the two sides will integrate their strengths in brands, products, and solutions. The partnership will focus on developing high-quality product portfolios and smart laboratory solutions tailored to the needs of county-level regional medical centers.
Beckman Coulter and Health Genetech Sign Strategic Cooperation Agreement
On September 18, 2026, during NCLM 2026, Beckman Coulter and Health Genetech officially signed a strategic cooperation agreement, marking the successful completion of their Phase 1 collaboration and the launch of Phase 2.
Building on their previous partnership, the two companies will further strengthen collaboration in technology development, clinical research, and market promotion. Together, they aim to develop innovative products tailored to the needs of local clinical and laboratory settings, enhance laboratory testing capabilities, and contribute to the high-quality development of healthcare in China.
DIRUI Medical’s Fully Automated Urinalysis System Deployed in Croatia
DIRUI Medical recently announced the deployment of its FUS-560+H-1800 fully automated urinalysis system at Sveti Duh Clinical Hospital, a leading public hospital in Zagreb, Croatia. The installation marks another step in DIRUI Medical’s expansion of its advanced urinalysis solutions in the Croatian healthcare market. The new system is expected to support efficient and standardized urine testing while further strengthening DIRUI Medical’s presence in the European diagnostics market.
